FDAFDA · Food and drugs·Recall number D-0006-2022
Potassium Chloride Extended-Release Tablets, USP 10 mEq (750 mg), 500 Tablets, Rx Only, Manufactured by: Strides Shasun Limited, Bengaluru - 562106, India, Distributed by: Strides Pharma In., East Brunswick, NJ 08816, NDC 64380-861-07.
Published October 20, 2021 · Recall initiated: September 27, 2021
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- POTASSIUM CHLORIDE
- Manufacturer
- Strides Pharma Inc.
- Distributor
- Nationwide
- UPC
- 0364380860068
- Lot
- Lot 7240840A, exp. 12/31/2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.